Philipp Harter

2006–2025 年に発表

159
論文数
25,849
被引用数
76
h 指数
149
i10 指数

被引用数

Philipp Harter の年別被引用数1998 年: 被引用 2 件2008 年: 被引用 4 件2009 年: 被引用 6 件2010 年: 被引用 26 件2011 年: 被引用 38 件2012 年: 被引用 56 件2013 年: 被引用 72 件2014 年: 被引用 90 件2015 年: 被引用 141 件2016 年: 被引用 197 件2017 年: 被引用 250 件2018 年: 被引用 227 件2019 年: 被引用 928 件2020 年: 被引用 1,132 件2021 年: 被引用 1,055 件2022 年: 被引用 852 件2023 年: 被引用 765 件2024 年: 被引用 1,391 件2025 年: 被引用 694 件2026 年: 被引用 16 件1999〜2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,770 件、この内訳の 17.8%中国: 引用元論文 905 件、この内訳の 9.1%イギリス: 引用元論文 763 件、この内訳の 7.6%イタリア: 引用元論文 720 件、この内訳の 7.2%ドイツ: 引用元論文 525 件、この内訳の 5.3%フランス: 引用元論文 469 件、この内訳の 4.7%スペイン: 引用元論文 412 件、この内訳の 4.1%カナダ: 引用元論文 396 件、この内訳の 4%日本: 引用元論文 315 件、この内訳の 3.2%オーストラリア: 引用元論文 306 件、この内訳の 3.1%オランダ: 引用元論文 278 件、この内訳の 2.8%ベルギー: 引用元論文 242 件、この内訳の 2.4%
0%17.8%その他 28.7%

分野

  • Medicine75.2%
  • Biochemistry, Genetics and Molecular Biology17.5%
  • Immunology and Microbiology2.1%
  • Computer Science0.7%
  • Neuroscience0.7%
  • Engineering0.6%
  • その他3.2%

トピック

  • Ovarian cancer diagnosis and treatment14.2%
  • PARP inhibition in cancer therapy11%
  • Endometrial and Cervical Cancer Treatments5.1%
  • DNA Repair Mechanisms3.5%
  • BRCA gene mutations in cancer3.2%
  • Intraperitoneal and Appendiceal Malignancies2.8%
  • その他60.2%

共著者

全論文

検索で開く
  1. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 2,040

  2. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fiona Nussey, Andrew R. Clamp, Richard T. Penson, Amit M. Oza, A. Poveda Velasco, Manuel Rodrigues, Jean‐Pierre Lotz, Frédèric Selle, Isabelle Ray‐Coquard, Diane Provencher, Aleix Prat Aparicio, Laura Vidal Boixader, Clare L. Scott, Kenji Tamura, Mayu Yunokawa, Alla Lisyanskaya, Jacques Médioni, Nicolas Pécuchet, Coraline Dubot, Thibault De La Motte Rouge, Marie‐Christine Kaminsky, B. Weber, Alain Lortholary, Christine Parkinson, Jonathan A. Ledermann, Sarah Williams, Susana Banerjee, Jonathan A. Cosin, James Hoffman, Richard T. Penson, Marie Plante, Allan Covens, Gabe S. Sonke, Florence Joly, Anne Floquet, Susana Banerjee, Holger W. Hirte, Amnon Amit, Tjoung-Won Park-Simon, Koji Matsumoto, Sergei Tjulandin, Jae‐Hoon Kim, Laurence Gladieff, Roberto Sabbatini, David M. O’Malley, Patrick Timmins, Daniel Kredentser, Nuria Laínez Milagro, M.P. Barretina Ginesta, Ariadna Tibau Martorell, Alfonso Gómez de Liaño, Belén Ojeda González, Linda Mileshkin, Masaki Mandai, Ingrid Boere, Petronella B. Ottevanger, Joo‐Hyun Nam, Elias Abdo Filho, Salima Hamizi, Francesco Cognetti, David Warshal, Elizabeth Dickson-Michelson, Scott Kamelle, Nathalie D. McKenzie, Gustavo C. Rodriguez, Deborah K. Armstrong, Eva Chalas, Paul Celano, Kian Behbakht, Susan A. Davidson ほか 21 名 - The Lancet Oncology 2017 被引用: 1,863

  3. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , - Annals of Oncology 2022 被引用: 638

  4. Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 372

  5. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , - Annals of Oncology 2023 被引用: 388

  6. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo De Giorgi, Maria Bjurberg, Michael A. Gold, David M. O’Malley, Brigitte Honhon, Christof Vulsteke, Eveline Cuypere, Hannelore Denys, Jean‐François Baurain, Claudio Zamagni, Meaghan Tenney, Mary E. Gordinier, William H. Bradley, Matthew Schlumbrecht, Nicola M. Spirtos, Nicole Concin, Sven Mahner, Giovanni Scambia, Charles A. Leath, Robin Farias‐Eisner, Joshua M. Cohen, Carolyn Muller, Sumeet Bhatia - The Lancet Oncology 2021 被引用: 394

  7. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 339

  8. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,891

  9. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophie Abadie‐Lacourtoisie, Claudia Andreetta, Nerea Anzizar, Daiseuke Aoki, Maria-Pilar Barretina-Ginesta, Marco Johannes Battista, Charlotte Béllier, Anne Gry Bentzen, Dominique Berton, Bertrand Billemont, Line Bjørge, Maria Bjurberg, Destin Black, Alessandra Bologna, Elena Ioana Braicu, Cláudia Casanova, Radoslav Chekerov, Annick Chevalier, Juan Cueva, Bastian Czogalla, Nicolas Delanoy, Dominik Denschlag, Oscar Derke, Michael Eichbaum, Takayuki Enomoto, Carmen Esteban, Michel Fabbro, Tanja Fehm, Annamaria Ferrero, Markus C. Fleisch, Anne Floquet, Antonio Frassoldati, Lydia Gaba, Angiolo Gadducci, Yolanda García García, Elena Geuna, Eva Guerra, Lars Hanker, Anne‐Claire Hardy‐Bessard, Philipp Harter, Kosei Hasegawa, Kristina Hellman, Ana Herrero, Felix Hilpert, Dionyssios Katsaros, M. Koegel, Anthoula Koliadi, Jean‐Emmanuel Kurtz, Bjoern Lampe, Andrea Alberto Lissoni, Alain Lortholary, Giorgia Mangili, Laura Mansi, Frederik Marmé, Cara Mathews, William Mina, Shinichiro Minobe, Katherine Moxley, Shoji Nagao, Ornella Nicoletto, Koji Nishino, Hiroshi Nishio, Shin Nishio, Ana Oaknin, Michaela Onstad, Beatriz Pardo, José Alejandro Pérez Fidalgo, Carmela Pisano, Andrés Poveda, Julia Caroline Radosa ほか 21 名 - The Lancet 2023 被引用: 209

  10. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Scambia, Maria Ornella Nicoletto, Fiona Nussey, Andrew R. Clamp, Richard T. Penson, Amit M. Oza, A. Poveda Velasco, Manuel Rodrigues, Jean‐Pierre Lotz, Frédèric Selle, Isabelle Ray‐Coquard, Diane Provencher, Aleix Prat Aparicio, Laura Vidal Boixader, Clare L. Scott, Kenji Tamura, Mayu Yunokawa, Alla Lisyanskaya, Jacques Médioni, Nicolas Pécuchet, Coraline Dubot, Thibault De La Motte Rouge, Marie‐Christine Kaminsky, B. Weber, Alain Lortholary, Christine Parkinson, Jonathan A. Ledermann, Sarah Williams, Susana Banerjee, Jonathan A. Cosin, James Hoffman, Richard T. Penson, Marie Plante, Allan Covens, Gabe S. Sonke, Florence Joly, Anne Floquet, Susana Banerjee, Holger W. Hirte, Amnon Amit, Tjoung-Won Park-Simon, Koji Matsumoto, Sergei Tjulandin, Jae‐Hoon Kim, Laurence Gladieff, Roberto Sabbatini, David M. O’Malley, Patrick Timmins, Daniel Kredentser, Nuria Laínez Milagro, M.P. Barretina Ginesta, Ariadna Tibau Martorell, Alfonso Gómez de Liaño, Belén Ojeda González, Linda Mileshkin, Masaki Mandai, Ingrid Boere, Petronella B. Ottevanger, Joo‐Hyun Nam, Elias Abdo Filho, Salima Hamizi, Francesco Cognetti, David Warshal, Elizabeth Dickson-Michelson, Scott Kamelle, Nathalie D. McKenzie, Gustavo C. Rodriguez, Deborah K. Armstrong, Eva Chalas, Paul Celano ほか 23 名 - The Lancet Oncology 2021 被引用: 416

  11. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

    著者: , , , , , - Cancer 2009 被引用: 1,614

  12. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 1,443

  13. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Alejandro Pérez Fidalgo, Sandro Pignata, Pedro T. Ramírez, Isabelle Ray‐Coquard, Ignacio Romero, Giovanni Scambia, Jalid Sehouli, Ronnie Shapira‐Frommer, Sudha Sundar, David S.P. Tan, Çağatay Taşkıran, Willemien J. van Driel, Ignace Vergote, François Planchamp, Cristiana Sessa, Anna Fagotti - Annals of Oncology 2024 被引用: 284

  14. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 600

  15. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 315

  16. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susana Banerjee, Massimo Barberis, M.P. Barretina Ginesta, J.F. Baurain, Margherita Bignami, Line Bjørge, Paweł Blecharz, Ilan Bruchim, ME Capilna, Nicoletta Cerana, Americo Cicchetti, Dearbhaile Catherine Collins, Nicole Concin, Maurizio D’Incalci, Brittany A. Davidson, Thibault De La Motte Rouge, Pierandrea De Iaco, Fuat Demirkıran, Hannelore Denys, Thilo Doerk, Anne Dørum, Annamaria Ferrero, Alejandro Perez Fidalgo, Maurizio Genuardi, Laurence Gladieff, Rosalind Glasspool, Christoph Grimm, Murat Gültekin, E. Hahnen, Annette Hasenburg, Alinta Hegmane, Viola Heinzelmann, Estrid Høgdall, Ramūnas Janavičius, Sonata Jarmalaitė, Roshni Kalachand, Radka Kaneva, Saadettin Kılıçkap, Roman Kocián, D. Kolencik, Rebecca Kristeleit, Anna Kryzhanivska, Alexandra Léary, Birthe Lemley, Marjolijn J. L. Ligtenberg, José Antonio López‐Guerrero, Christopher J. Lord, E. Åvall‐Lundqvist, Johanna Mäenpää, Sven Mahner, Frederik Marmé, Christian Marth, Iain A. McNeish, Sabine Merkelbach‐Bruse, Marian J.E. Mourits, Nicola Normanno, Ana Oaknin, Kristiina Ojamaa, C. Papdimitriou, F. Penault-Llorca, Anna Myriam Perrone, Sandro Pignata, Eli Pikarsky, Étienne Rouleau, María Jesús Rubio, Anna Sapino, Barbara Schmalfeldt, Jalid Sehouli, Roni Shapira, Karina Dahl Steffensen ほか 12 名 - Annals of Oncology 2021 被引用: 164

  17. Treatment of recurrent ovarian cancer

    著者: , , , , - Annals of Oncology 2017 被引用: 354

  18. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Emmanuel Kurtz, Sven Ackermann, C. Anthuber, Mustafa Aydoğdu, Angelika Baldauf, Wolfgang Bauer, Dirk Behringer, Antje Belau, Alexandra Bender, Cosima Brucker, Alexander Burges, Ulrich Canzler, Trygve Daabach, Dominik Denschlag, Mustafa Deryal, Steffen Dörfel, Juliane Ebert, Ahmed El-Balat, Tanja Fehm, Susanne Maria Feidicker, Gabriele Feisel-Schwickardi, R. Felberbaum, Matthias Frank, Gerhard Gebauer, Bernd Gerber, Axel Gerhardt, Andrea Gräfe, Martin Grießhammer, Eva‐Maria Grischke, Isolde Gröll, Martina Gropp‐Meier, Dietrich Hager, Volker Hanf, Carla Hannig, Peer Hantschmann, Philipp Harter, Tanja Hauzenberger, Uwe Herwig, Martin Heubner, Carsten Hielscher, Felix Hilpert, T Hitschold, Manfred Hofmann, Christian Jackisch, Wolfgang Janni, Ludwig Kiesel, Yon‐Dschun Ko, H. Koch, Petra Krabisch, Peter Krieger, Thomas Kubin, Thorsten Kühn, Björn Lampe, P. Ledwon, Sabine Lemster, B. Lex, Clemens Liebrich, Ralf Lorenz, Hans‐Joachim Lück, Sven� Mahner, Peter Mallmann, Frederik Marmé, Werner Meier, Wolfgang Meinerz, Götz Menke, Volker Möbus, Thomas Müller, Volker Müller, Tanja Neunhöffer, Angelika Ober ほか 87 名 - The Lancet Oncology 2020 被引用: 162

  19. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2022 被引用: 70

  20. Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

    著者: , , , , , , , , , , - Gynecologic Oncology 2016 被引用: 230

  21. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

    著者: , , , , , , , , , - Annals of Oncology 2012 被引用: 340

  22. TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

    著者: , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2019 被引用: 184

  23. Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - International Journal of Gynecological Cancer 2023 被引用: 60

  24. Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

    著者: , , , , , , , , , , , , , , , , , , , - Gynecologic Oncology 2021 被引用: 90